Urinary tract infection due to trichosporon asahii in a patient after retrograde ureteroscopic lithotripsy: A case report
Main Article Content
Abstract
Trichosporon asahii is considered to be an infectious agent with high mortality rate and is common in immunocompromised patients. Trichosporonosis can occasionally occur in immunocompetent patients after surgery or prolonged antibiotic treatment. We reported a case of urinary tract fungal infection after treatment of sepsis and retrograde ureteroscopic lithotripsy. A 65-year-old female patient was admitted to the hospital with fever and left lower back pain. The patient was diagnosed with mycosis on the 33rd day after admission, treated with Voriconazole and discharged after 3 days.
Article Details
Keywords
Trichosporon asahii, Trichosporon
References
1. Arnaldo LC, Ana CBP and Guilherme MC. Current Knowledge of Trichosporon spp. and Trichosporonosis. Clinical microbiology reviews. 2011; 24(4):682–700.
2. Joseph WG and Virginia LK. Trichosporon asahii infection in an advanced AIDS patient and literature review. AIDS. 2008; 22(6): 793-795.
3. Haitao L, Meihong G, Congmin W et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiology and Infection. 2020; 148: 169-176.
4. Miral AM , Dawood HY , Du’a H et al. Complicated Trichosporon asahii mastoiditis in immunocompetent child. BMC Infectious Diseases. 2021; 21:1229. Doi: 10.1186/s12879-021-06915-w.
5. Wdson LLK, Pedro MP, Simone BM. Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview. Brazilian Journal of Microbiology. 2022; 53:1221–1229.
6. Kontoyiannis DP et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scandinavian Journal of Infectious Diseases. 2004; 36: 564–569.
7. Ruan SY, Chien JY and Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clinical Infectious Diseases. 2009; 49: 11-17.
8. Maiken CA, Teun B, Murat A et al. ESCMID/ECMM Joint clinical guideline for the diagnosis and management of rare invasive yeast infections. Clinical Microbiology and Infection. 2013; 20: 76–98.
2. Joseph WG and Virginia LK. Trichosporon asahii infection in an advanced AIDS patient and literature review. AIDS. 2008; 22(6): 793-795.
3. Haitao L, Meihong G, Congmin W et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiology and Infection. 2020; 148: 169-176.
4. Miral AM , Dawood HY , Du’a H et al. Complicated Trichosporon asahii mastoiditis in immunocompetent child. BMC Infectious Diseases. 2021; 21:1229. Doi: 10.1186/s12879-021-06915-w.
5. Wdson LLK, Pedro MP, Simone BM. Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview. Brazilian Journal of Microbiology. 2022; 53:1221–1229.
6. Kontoyiannis DP et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scandinavian Journal of Infectious Diseases. 2004; 36: 564–569.
7. Ruan SY, Chien JY and Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clinical Infectious Diseases. 2009; 49: 11-17.
8. Maiken CA, Teun B, Murat A et al. ESCMID/ECMM Joint clinical guideline for the diagnosis and management of rare invasive yeast infections. Clinical Microbiology and Infection. 2013; 20: 76–98.